Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

ICU

SeaStar Medical Holding Corp

Dec 08 • 04:00PM ET

0.5600

Dollar change +0.0800
Percentage change 16.67	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-3.06	Insider Own	64.68%	Shs Outstand	42.12M	Perf Week	2.98%
Market Cap	23.59M	Forward P/E	-	EPS next Y	-0.61	Insider Trans	0.37%	Shs Float	14.88M	Perf Month	-16.42%
Income	-42.32M	PEG	-	EPS next Q	-0.13	Inst Own	5.31%	Short Float / Ratio	3.54% / 0.03	Perf Quarter	229.41%
Sales	0.00M	P/S	-	EPS this Y	58.93%	Inst Trans	-0.30%	Short Interest	0.53M	Perf Half Y	-4.18%
Book/sh	-0.58	P/B	-	EPS next Y	46.96%	ROA	-77.23%	Target Price	2.00	Perf Year	-86.89%
Cash/sh	0.00	P/C	336.96	EPS next 5Y	-	ROE	-103.15%	52W Range	0.16 - 6.34	Perf YTD	-86.34%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-	52W High	-91.17%	Beta	-1.19
Dividend %	-	Quick Ratio	0.18	Sales past 5Y	0.00%	Gross Margin	-	52W Low	245.68%	ATR	0.09
Employees	9	Current Ratio	0.18	Sales Q/Q	-	Oper. Margin	0.00%	RSI (14)	51.05	Volatility	11.62% 15.49%
Optionable	No	Debt/Eq	-	EPS Q/Q	-679.79%	Profit Margin	-	Rel Volume	0.24	Prev Close	0.48
Shortable	Yes	LT Debt/Eq	-	Earnings	Nov 14 AMC	Payout	-	Avg Volume	16.66M	Price	0.56
Recom	1.00	SMA20	9.77%	SMA50	-8.79%	SMA200	-41.72%	Volume	3,998,965	Change	16.67%

Nov-14-23 04:04PM	SeaStar Medical Reports Third Quarter 2023 Financial Results and Provides a Business Update (GlobeNewswire)
Oct-31-23 08:00AM	Nuwellis' Strategic Partner, SeaStar Medical, Receives FDA Approvable Letter for Its Pediatric Selective Cytopheretic Device (GlobeNewswire) -17.93%
Oct-30-23 09:00PM	Discover the Next Nokia: 3 Penny Stocks With Big Potential (InvestorPlace)
08:00AM	FDA Issues Approvable Letter for SeaStar Medical's Selective Cytopheretic Device for Pediatric Patients (GlobeNewswire)
Oct-18-23 08:30AM	FDA Grants SeaStar Medical's Selective Cytopheretic Device Breakthrough Device Designation for Hepatorenal Syndrome (GlobeNewswire) +70.05%
08:30AM	Loading…
Oct-05-23 08:30AM	SeaStar Medical to Present at the Dawson James Small Cap Growth Conference on October 12, 2023 (GlobeNewswire)
Oct-03-23 04:05PM	SeaStar Medical Provides Regulatory Update Regarding Selective Cytopheretic Device Use in Pediatric Acute Kidney Injury Under a Humanitarian Device Exemption (GlobeNewswire) +41.49%
Oct-02-23 07:08PM	3 Micro-Cap Stocks Set to Explode Higher (InvestorPlace) +57.95%
Sep-29-23 08:30AM	FDA Grants Breakthrough Device Designation to SeaStar Medical's Selective Cytopheretic Device for Cardiorenal Syndrome (GlobeNewswire) +41.18%
Sep-21-23 09:35AM	Dawson James Securities Announces October Date for 8th Annual Small Cap Growth Conference (GlobeNewswire) -10.58%
Aug-29-23 08:00AM	Case Series of Three Critically Ill Children with Acute Kidney Injury Safely Treated with SeaStar Medicals Selective Cytopheretic Device Published in the Journal Blood Purification (GlobeNewswire)
Aug-22-23 08:00AM	SeaStar Medical to Hold Business Update Conference Call Today at 4:00 p.m. Eastern Time (GlobeNewswire) +5.23%
Aug-14-23 04:35PM	SeaStar Medical Reports Second Quarter 2023 Financial Results and Provides a Business Update (GlobeNewswire)
Jun-30-23 08:00AM	SeaStar Medical to Sponsor the Critical Care Time Podcast Series Covering Vital Medical Issues for Healthcare Professionals Who Care for Critically Ill Patients (GlobeNewswire)
Jun-20-23 04:05PM	First Patient Enrolled in SeaStar Medicals Pivotal Clinical Trial with the Selective Cytopheretic Device in Adults with Acute Kidney Injury (GlobeNewswire)
08:00AM	Loading…
Jun-14-23 08:00AM	SeaStar Medical to Present at the Maxim Group Virtual Healthcare Conference Hosted by M-Vest on June 21, 2023 (GlobeNewswire)
May-15-23 04:45PM	SeaStar Medical Reports First Quarter 2023 Financial Results and Provides a Business Update (GlobeNewswire) +8.52%
May-10-23 08:00AM	SeaStar Medical to Present at the JMP Securities Life Sciences Conference on May 16, 2023 (GlobeNewswire) -39.69%
May-09-23 04:05PM	SeaStar Medical Provides Regulatory Update Related to its HDE Application for Pediatric Selective Cytopheretic Device (GlobeNewswire)
Apr-19-23 08:00AM	SeaStar Medical Announces Activation of First Clinical Site in Pivotal Trial with Selective Cytopheretic Device in Critically Ill Adults with Acute Kidney Injury (GlobeNewswire)
Mar-30-23 07:23PM	SeaStar Medical Reports 2022 Financial Results and Provides a Business Update (GlobeNewswire)
Mar-21-23 07:00AM	Presenting on the Emerging Growth Conference on March 22 Register Now (GlobeNewswire)
Mar-16-23 08:00AM	SeaStar Medical Holding Corporation Closes Initial $3.3 Million Tranche of $9.8 Million Private Placement (GlobeNewswire) -9.72%
Mar-15-23 04:05PM	SeaStar Medical to Present at the Emerging Growth Virtual Conference on March 22, 2023 (GlobeNewswire) -7.30%
Feb-24-23 08:05AM	SeaStar Medicals Selective Cytopheretic Device to be Featured at the 5th Chronic Kidney Disease Drug Development Summit (GlobeNewswire)
Feb-15-23 04:01PM	SeaStar Medical Announces Details of the Selective Cytopheretic Device Pivotal Study in Critically ill Adults with Acute Kidney Injury (GlobeNewswire) +5.81%
Feb-14-23 04:05PM	SeaStar Medical to Hold Business Update Conference Call on February 15, 2023 (GlobeNewswire)
Feb-09-23 08:19AM	SeaStar Medical Receives FDA Approval to Begin Study with Selective Cytopheretic Device to Reduce Hyperinflammation in Adults with Acute Kidney Injury (GlobeNewswire) -15.21%
Jan-31-23 08:00AM	SeaStar Medical to Present at the Virtual Sequire Biotechnology Conference on February 2, 2023 (GlobeNewswire)
Jan-09-23 08:25AM	SeaStar Medical Submits Investigational Device Exemption (IDE) Application to FDA to Study a Novel Therapy to Reduce Hyperinflammation in Adult Acute Kidney Injury Patients (GlobeNewswire) +8.78%
01:35PM	Loading…
Dec-29-22 01:35PM	SeaStar Medical and Nuwellis Enter into a U.S. License and Distribution Agreement for SeaStar Medicals Selective Cytopheretic Device (SCD) for Pediatric Acute Kidney Injury (AKI) (GlobeNewswire) +9.92%
09:02AM	SeaStar Medical, Nuwellis Ink US Licensing Pact For Acute Kidney Injury Device For Pediatric Patients (Benzinga)
Dec-02-22 09:05AM	SeaStar Medical Bolsters Operational Expertise with Appointment of Thomas R. Mullen as Vice President of Operations and Product Development (GlobeNewswire)
Nov-29-22 09:05AM	SeaStar Medical Appoints Rick Barnett as Chairman of the Board of Directors (GlobeNewswire) -9.46%
Nov-17-22 08:27AM	SeaStar Medical Holding Corporation's (NASDAQ:ICU) top owners are individual investors with 51% stake, while49% is held by institutions (Simply Wall St.) -12.68%
Nov-07-22 12:30PM	SeaStar Medicals Lead Product Candidate, the Selective Cytopheretic Device (SCD), Included in Consensus Statement for Pediatric Acute Kidney Injury in First Pediatric Acute Disease Quality Initiative (ADQI) Meeting (GlobeNewswire) -10.11%
Nov-03-22 09:00AM	SeaStar Medical (Nasdaq: ICU) Announces Positive Interim Safety Findings from Ongoing Study Evaluating the Selective Cytopheretic Device (SCD) in Children (GlobeNewswire) -7.35%
Oct-31-22 09:25AM	SeaStar Medical (NASDAQ: ICU) Commences Trading on Nasdaq Capital Market and Outlines Corporate Strategy and Near-Term Catalysts (GlobeNewswire) -11.90%

Seastar Medical Holding Corp. operates as a holding company whose subsidiaries manufacture and supply medical devices. The company is headquartered in Denver, CO.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Van Heel Kenneth	Director	Nov 22	Buy	0.40	100,000	40,000	116,400	Nov 27 04:05 PM
Chung Kevin	Chief Medical Officer	May 30	Buy	0.47	12,543	5,953	68,125	Jun 01 04:01 PM
Russell Richard D.	Director	May 25	Buy	0.50	20,000	10,000	27,978	May 30 04:01 PM
Chung Kevin	Chief Medical Officer	May 18	Buy	0.70	7,500	5,248	55,582	May 22 04:13 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ICU

SeaStar Medical Holding Corp

Upgrade your FINVIZ experience